| __timestamp | Arrowhead Pharmaceuticals, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 14683100000 |
| Thursday, January 1, 2015 | 382000 | 14921500000 |
| Friday, January 1, 2016 | 158333 | 15567200000 |
| Sunday, January 1, 2017 | 31407709 | 16801100000 |
| Monday, January 1, 2018 | 16142321 | 16811600000 |
| Tuesday, January 1, 2019 | 168795577 | 17598300000 |
| Wednesday, January 1, 2020 | 87992066 | 19056500000 |
| Friday, January 1, 2021 | 138287000 | 21005600000 |
| Saturday, January 1, 2022 | 232810000 | 21911600000 |
| Sunday, January 1, 2023 | 240735000 | 27041900000 |
| Monday, January 1, 2024 | 3551000 | 36624400001 |
Cracking the code
In the competitive landscape of pharmaceuticals, gross profit is a key indicator of a company's financial health and market dominance. Over the past decade, Eli Lilly and Company has consistently outperformed Arrowhead Pharmaceuticals, Inc. in generating gross profit. From 2014 to 2023, Eli Lilly's gross profit surged by approximately 84%, peaking at an impressive $27 billion in 2023. In contrast, Arrowhead Pharmaceuticals, while showing growth, reached a maximum gross profit of around $240 million in the same year.
Eli Lilly's robust financial performance can be attributed to its diverse product portfolio and strategic market positioning. Meanwhile, Arrowhead's focus on innovative RNAi therapeutics is promising, yet it remains in the growth phase. As the pharmaceutical industry evolves, these companies' financial trajectories will be crucial to watch, especially as Arrowhead continues to expand its market presence.
Eli Lilly and Company vs Vertex Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Gross Profit Comparison: Eli Lilly and Company and Sanofi Trends
Gross Profit Trends Compared: Eli Lilly and Company vs Teva Pharmaceutical Industries Limited
Gross Profit Comparison: Eli Lilly and Company and United Therapeutics Corporation Trends
Eli Lilly and Company vs Vericel Corporation: A Gross Profit Performance Breakdown
Research and Development Investment: Eli Lilly and Company vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Eli Lilly and Company and Ligand Pharmaceuticals Incorporated
Who Generates Higher Gross Profit? Eli Lilly and Company or Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: Eli Lilly and Company and Travere Therapeutics, Inc. Trends
Eli Lilly and Company vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Corcept Therapeutics Incorporated and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis